10 October 2024
The Alumasc Group plc
("Alumasc" or the "Group")
Notice of Capital Markets Event
Alumasc (ALU.L), the premium sustainable building products, systems and solutions Group, announces that it is hosting a Capital Markets Event this afternoon in
The presentation from the senior management team and divisional leaders will provide an in-depth look at the Group's strategy across its three core divisions: Water Management, Building Envelope and Housebuilding Products.
The discussion will be focused on the Group's proven strategy, which has delivered a strong performance since 2019; and the solid foundations which underpin the Group's medium term growth ambitions.
No material or price sensitive information will be disclosed at the event.
If you are an institutional investor or sell-side analyst and would like to attend the event or webinar, please contact Camarco via alumasc@camarco.co.uk.
The presentation and a recording of the event will follow on the Group's website: www.alumasc.co.uk.
Enquiries:
The Alumasc Group plc +44 (0)1536 383844
Paul Hooper (Chief Executive)
Simon Dray (Group Finance Director)
Peel Hunt (Broker) +44 (0)207 418 8831
Mike Bell
Ed Allsopp
Cavendish Capital Markets Ltd (Nominated Adviser) +44 (0)207 220 0561
Julian Blunt
Edward Whiley
Camarco (Financial PR) alumasc@camarco.co.uk
Ginny Pulbrook +44 (0)203 757 4980
Rosie Driscoll
Tilly Butcher
Notes to Editors:
Alumasc is a UK-based supplier of premium sustainable building products, systems and solutions. Almost 80% of Group sales are driven by building regulations and specifications (architects and structural engineers) because of the performance characteristics offered.
The Group has three business segments with strong positions and brands in their individual markets. The three segments are: Water Management; Building Envelope; and Housebuilding Products.
RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.